NCT04190446 2026-03-16
A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer
Mayo Clinic
Phase 2 Active not recruiting
Clinical Trials
15 trialsNCT05320406 2026-02-12
REVELUTION
Emory University
Phase 2 Active not recruiting
NCT03624660 2026-02-10
PR11
University of Florida
Phase 2 Active not recruiting
NCT04968990 2026-01-23
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
St. Jude Children's Research Hospital
Phase 2 Recruiting
NCT01950351 2025-12-22
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT06200259 2025-12-18
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
Covenant Health Cancer Center
Phase NA Recruiting
NCT05350475 2025-03-07
Protons Vs. Photons for High-risk Prostate Cancer
University of Aarhus
Phase NA Recruiting
NCT00831623 2023-03-13
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
Loma Linda University
Phase NA Completed
NCT01045226 2023-02-01
Proton Radiation Therapy in Treating Patients With Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT01520038 2019-11-26
Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT02040610 2019-04-05
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
Provision Center for Proton Therapy
Phase NA Unknown
NCT03285815 2017-09-18
Prostate Cancer - Localized Adenocarcinoma Proton Therapy
National Cancer Center, Korea
Phase NA Unknown
NCT00585962 2017-09-05
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
Massachusetts General Hospital
Phase 2 Completed
NCT02315989 2017-01-13
Early-Phase Safety of Proton Therapy Equipment
Chang Gung Memorial Hospital
Phase NA Completed
NCT01603420 2016-03-14
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Proton Collaborative Group
Phase 2/3 Terminated